Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04084665|
Recruitment Status : Withdrawn (COVID-19 Pandemic)
First Posted : September 10, 2019
Last Update Posted : June 5, 2020
Janssen Scientific Affairs, LLC
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Estimated Primary Completion Date :||July 30, 2020|
|Estimated Study Completion Date :||July 30, 2020|